Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of modulation of TGR5 activity in a human or animal subject are also provided for the treatment diseases mediated by TGR5.
[EN] HETEROCYCLIC MODULATORS OF TGR5<br/>[FR] MODULATEURS HÉTÉROCYCLIQUES DE TGR5
申请人:KALYPSYS INC
公开号:WO2009026241A1
公开(公告)日:2009-02-26
Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of modulation of TGR5 activity in a human or animal subject are also provided for the treatment diseases mediated by TGR5.